These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33307874)

  • 41. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
    Bejar N; Tat TT; Kiss DL
    Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.
    Shan ZX; Lin QX; Yang M; Deng CY; Kuang SJ; Zhou ZL; Xiao DZ; Liu XY; Lin SG; Yu XY
    Mol Cell Biochem; 2009 Mar; 323(1-2):81-9. PubMed ID: 19037714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo delivery aspects of miRNA, shRNA and siRNA.
    Khatri N; Rathi M; Baradia D; Trehan S; Misra A
    Crit Rev Ther Drug Carrier Syst; 2012; 29(6):487-527. PubMed ID: 23176057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA: a small molecule with a big biological impact.
    Zhou X; Yang PC
    Microrna; 2012; 1(1):1. PubMed ID: 25048083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chemical Approaches for RNAi Drug Development].
    Saito-Tarashima N
    Yakugaku Zasshi; 2020; 140(10):1259-1268. PubMed ID: 32999205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA interference of GADD153 protects photoreceptors from endoplasmic reticulum stress-mediated apoptosis after retinal detachment.
    Zhu H; Qian J; Wang W; Yan Q; Xu Y; Jiang Y; Zhang L; Lu F; Hu W; Zhang X; Wang F; Sun X
    PLoS One; 2013; 8(3):e59339. PubMed ID: 23555658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
    Fish RJ; Kruithof EK
    BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The versatility of oligonucleotides as potential therapeutics.
    Eckstein F
    Expert Opin Biol Ther; 2007 Jul; 7(7):1021-34. PubMed ID: 17665991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.
    Anesti AM; Simpson GR; Price T; Pandha HS; Coffin RS
    BMC Cancer; 2010 Sep; 10():486. PubMed ID: 20836854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular mechanisms of RNA-triggered gene silencing machineries.
    Li Z; Rana TM
    Acc Chem Res; 2012 Jul; 45(7):1122-31. PubMed ID: 22304792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-transcriptional gene silencing by siRNAs and miRNAs.
    Filipowicz W; Jaskiewicz L; Kolb FA; Pillai RS
    Curr Opin Struct Biol; 2005 Jun; 15(3):331-41. PubMed ID: 15925505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of developmental competence of cloned male pig embryos by short hairpin ribonucleic acid (shRNA) vector-based but not small interfering RNA (siRNA)-mediated RNA interference (RNAi) of Xist expression.
    Yang X; Wu X; Yang Y; Gu T; Hong L; Zheng E; Xu Z; Zeng F; Shi J; Zhou R; Cai G; Wu Z; Li Z
    J Reprod Dev; 2019 Dec; 65(6):533-539. PubMed ID: 31631092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small RNA: can RNA interference be exploited for therapy?
    Wall NR; Shi Y
    Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
    Barata P; Sood AK; Hong DS
    Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNA therapeutics: updates and future potential.
    Zhang C; Zhang B
    Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. siRNA vs. shRNA: similarities and differences.
    Rao DD; Vorhies JS; Senzer N; Nemunaitis J
    Adv Drug Deliv Rev; 2009 Jul; 61(9):746-59. PubMed ID: 19389436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.